Abstract
Pancreatic tumors are rich in immune cell infiltrates that include CD4+ T-cell subsets encompassing both regulatory T cells and TH17 cells. Rather than protecting the organism by exerting an anticancer effect, these T-cell subsets promote tumor formation. Thus, re-activation of antitumor immunity should be investigated for use in pancreatic cancer prevention and therapy.
Original language | English (US) |
---|---|
Article number | e29125 |
Journal | OncoImmunology |
Volume | 3 |
Issue number | 6 |
DOIs | |
State | Published - 2014 |
Externally published | Yes |
Keywords
- CD4 T cells
- CD8 T cells
- Il-17
- Kras
- Mouse model
- Pancreatic cancer
- Regulatory T cells
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Oncology